Antiphospholipid Syndrome (APS)

Antiphospholipid Syndrome (APS) is associated with a tendency to abnormal blood clotting and other features. Problems in patients with APS can include clots in either veins or arteries, skin changes, low platelet counts, heart valve abnormalities and the risk of pregnancy loss. APS can occur in combination with another disease, most commonly systemic lupus erytematosus, or can occur with no associated condition. APS diagnosis requires at least two positive blood tests (lupus anticoagulant, anticardiolipin antibody or anti-ß2 glycoprotein 1) spaced at least 3 months apart, since antibodies that suggest this condition can occur for brief periods in patients without APS. Patients with APS who develop clots generally require long-term blood thinning.

Overview Text Audio Video
Antiphospholipid Antibody Syndrome - In-Depth Overview View Article
"Antiphospholipid Syndrome: Essential Information and Support" FAQs View Article

Complications and Secondary Illness Text Audio Video
Common Pulmonary Problems in Rheumatology View Article View Video Presentation

Clinical Trials Text Audio Video
Cognitive Dysfunction, Diffusion Tensor Imaging and Functional Magnetic Resonance Imaging (MRI) in Antiphospholipid Antibody (aPL)-negative Systemic Lupus Erythematosus (SLE) versus aPL-positive non-SLE Patients View Article
Effects of Fluvastatin on Proinflammatory and Prothrombotic markers in Antiphospholipid Syndrome View Article
Autoimmune Disease Registry and Repository View Article
PROMISSE: Predictors of Pregnancy Outcome: Biomarkers in Anti-Phospholipid Antibody Syndrome (APS) and Systemic Lupus Erythematosus (SLE) View Article
RITAPS: A Pilot Study Of Rituximab For The Anticoagulation-Resistant Manifestations Of Antiphospholipid Syndrome (APS) View Article